CONCLUSIONS: Clients prescribed guanfacine adjunctively with stimulants reported fewer side effects compared to monotherapy, supporting early adjunctive use in suitable cases. Blood pressure and heart rate remained stable across the cohort. Serial vital sign measurement was performed in 50% of cases.
